Trial intelligence / Profile preview

Exubera Initial Dose Comparison in T2DM

NCT00437489Phase 4Terminated

Sponsor
Pfizer
Start
Jun 2007
Primary completion
Dec 2007
Modality
Biologic
Countries
4
01

Overview

A Phase 4 trial of insulin human in type 2 diabetes mellitus (T2DM), sponsored by Pfizer. Started Jun 2007; status: terminated.

02

Drugs

insulin human
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00437489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00437489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call